Alterations of the bone marrow stromal microenvironment in adult patients with acute myeloid and lymphoblastic leukemias before and after allogeneic hematopoietic stem cell transplantation

References

• Taichman RS. Blood and bone: two tissues whose fates are intertwined to create the hematopoietic stem-cell niche. Blood. 2005;105:2631–2639.
   PubMed Web of Science ®Google Scholar
• Anthony BA, Link DC. Regulation of hematopoietic stem cells by bone marrow stromal cells. Trends Immunol. 2014;35:32–37.
   PubMed Web of Science ®Google Scholar
• Ehninger A, Trumpp A. The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in. J Exp Med. 2011;208:421–428.
   PubMed Web of Science ®Google Scholar
• Caplan AI. Mesenchymal stem cells. J Orthop Res. 1991;9:641–650.
   PubMed Web of Science ®Google Scholar
• Chertkov JL, Gurevitch OA, Udalov GA. Role of bone marrow stroma in hemopoietic stem cell regulation. Exp Hematol. 1980;8:770–778.
   PubMed Web of Science ®Google Scholar
• Horwitz EM, Le Blanc K, Dominici M, et al. Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement. Cytotherapy. 2005;7:393–395.
   PubMed Web of Science ®Google Scholar
• Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315–317.
   PubMed Web of Science ®Google Scholar
• Méndez-Ferrer S, Michurina TV, Ferraro F, et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature. 2010;466:829–834.
   PubMed Web of Science ®Google Scholar
• Park D, Sykes DB, Scadden DT. The hematopoietic stem cell niche. Front Biosci (Landmark Ed). 2012;17:30–39.
   PubMed Web of Science ®Google Scholar
• Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 1970;3:393–403.
   PubMedGoogle Scholar
• Koide Y, Morikawa S, Mabuchi Y, et al. Two distinct stem cell lineages in murine bone marrow. Stem Cells. 2007;25:1213–1221.
   PubMed Web of Science ®Google Scholar
• Castro-Malaspina H, Gay RE, Resnick G, et al. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood. 1980;56:289–301.
   PubMed Web of Science ®Google Scholar
• Nifontova I, Svinareva D, Petrova T, et al. Sensitivity of mesenchymal stem cells and their progeny to medicines used for the treatment of hematoproliferative diseases. Acta Haematol. 2008;119:98–103.
   PubMed Web of Science ®Google Scholar
• Kuznetsov SA, Friedenstein AJ, Robey PG. Factors required for bone marrow stromal fibroblast colony formation in vitro. Br J Haematol. 1997;97:561–570.
   PubMed Web of Science ®Google Scholar
• Bradstock KF, Gottlieb DJ. Interaction of acute leukemia cells with the bone marrow microenvironment: implications for control of minimal residual disease. Leuk Lymphoma. 1995;18:1–16.
   PubMed Web of Science ®Google Scholar
• van den Berk LCJ, van der Veer A, Willemse ME, et al. Disturbed CXCR4/CXCL12 axis in paediatric precursor B-cell acute lymphoblastic leukaemia. Br J Haematol. 2014;166:240–249.
   PubMed Web of Science ®Google Scholar
• Shalapour S, Eckert C, Seeger K, et al. Leukemia-associated genetic aberrations in mesenchymal stem cells of children with acute lymphoblastic leukemia. J Mol Med (Berl). 2010;88:249–265.
   PubMed Web of Science ®Google Scholar
• Menendez P, Catalina P, Rodríguez R, et al. Bone marrow mesenchymal stem cells from infants with MLL-AF4+ acute leukemia harbor and express the MLL-AF4 fusion gene. J Exp Med. 2009;206:3131–3141.
   PubMed Web of Science ®Google Scholar
• Blau O, Baldus CD, Hofmann W-K, et al. Mesenchymal stromal cells of myelodysplastic syndrome and acute myeloid leukemia patients have distinct genetic abnormalities compared with leukemic blasts. Blood. 2011;118:5583–5592.
   PubMed Web of Science ®Google Scholar
• Pontikoglou C, Kastrinaki M-C, Klaus M, et al. Study of the quantitative, functional, cytogenetic, and immunoregulatory properties of bone marrow mesenchymal stem cells in patients with B-cell chronic lymphocytic leukemia. Stem Cells Dev. 2013;22:1329–1341.
   PubMed Web of Science ®Google Scholar
• Vicente López Á, Vázquez García MN, Melen GJ, et al. Mesenchymal stromal cells derived from the bone marrow of acute lymphoblastic leukemia patients show altered BMP4 production: correlations with the course of disease. PLoS One. 2014;9:e84496.
   PubMed Web of Science ®Google Scholar
• Conforti A, Biagini S, Del Bufalo F, et al. Biological, functional and genetic characterization of bone marrow-derived mesenchymal stromal cells from pediatric patients affected by acute lymphoblastic leukemia. PLoS One. 2013;8:e76989.
   PubMed Web of Science ®Google Scholar
• Lisovsky MYa, Savchenko VG. Defect of stromal microenvironment in long term bone marrow cultures of patients with acute and chronic myelogenous leukemias. Leuk Lymphoma. 1995;19:145–152.
   PubMed Web of Science ®Google Scholar
• Campioni D, Bardi MA, Cavazzini F, et al. Cytogenetic and molecular cytogenetic profile of bone marrow-derived mesenchymal stromal cells in chronic and acute lymphoproliferative disorders. Ann Hematol. 2012;91:1563–1577.
   PubMed Web of Science ®Google Scholar
• Galotto M, Berisso G, Delfino L, et al. Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients. Exp Hematol. 1999;27:1460–1466.
   PubMed Web of Science ®Google Scholar
• Banfi A, Podestà M, Fazzuoli L, et al. High-dose chemotherapy shows a dose-dependent toxicity to bone marrow osteoprogenitors: a mechanism for post-bone marrow transplantation osteopenia. Cancer. 2001;92:2419–2428.
   PubMed Web of Science ®Google Scholar
• Georgiou KR, Scherer MA, King TJ, et al. Deregulation of the CXCL12/CXCR4 axis in methotrexate chemotherapy-induced damage and recovery of the bone marrow microenvironment. Int J Exp Pathol. 2012;93:104–114.
   PubMed Web of Science ®Google Scholar
• Devine SM, Hoffman R. Role of mesenchymal stem cells in hematopoietic stem cell transplantation. Curr Opin Hematol. 2000;7:358–363.
   PubMed Web of Science ®Google Scholar
• Bemark M, Holmqvist J, Abrahamsson J, et al. Translational Mini-Review Series on B cell subsets in disease. Reconstitution after haematopoietic stem cell transplantation – revelation of B cell developmental pathways and lineage phenotypes. Clin Exp Immunol. 2012;167:15–25.
   PubMed Web of Science ®Google Scholar
• Storek J, Geddes M, Khan F, et al. Reconstitution of the immune system after hematopoietic stem cell transplantation in humans. Semin Immunopathol. 2008;30:425–437.
   PubMed Web of Science ®Google Scholar
• Parovichnikova EN, Kliasova GA, Isaev VG, et al. [First results of Ph-negative acute lymphoblastic leukemia therapy of adults according to the protocol of Research Group of Russian Hematological Centers ALL-2009]. Ter Arkh. 2011;83:11–17.
   PubMed Web of Science ®Google Scholar
• Parovichnikova EN, Troitskaia VV, Kliasova GA, et al. [Treating patients with acute myeloid leukemias (AML) according to the protocol of the AML-01.10 Russian multicenter randomized trial: the coordinating center’s results]. Ter Arkh. 2014;86:14–23.
   PubMed Web of Science ®Google Scholar
• Kuzmina LA, Petinati NA, Parovichnikova EN, et al. Multipotent Mesenchymal Stromal Cells for the Prophylaxis of Acute Graft-versus-Host Disease-A Phase II Study. Stem Cells Int. 2012;2012:968213.
   PubMed Web of Science ®Google Scholar
• Petinati NA, Shipunova IN, Bigil’deev AE, et al. [Characteristics of stromal cell precursors in patients after allogeneic bone marrow transplantation]. Ter Arkh. 2013;85:95–99.
   PubMed Web of Science ®Google Scholar
• Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction. Anal Biochem. 1987;162:156–159.
   PubMed Web of Science ®Google Scholar
• Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3:1101–1108.
   PubMed Web of Science ®Google Scholar
• Lane SW. Bad to the bone. Blood. 2012;119:323–325.
   PubMed Web of Science ®Google Scholar
• Zhao Z-G, Liang Y, Li K, et al. Phenotypic and functional comparison of mesenchymal stem cells derived from the bone marrow of normal adults and patients with hematologic malignant diseases. Stem Cells Dev. 2007;16:637–648.
   PubMed Web of Science ®Google Scholar
• Yin W-J, Yang P-D, Huang Y-Z, et al. [Comparison of biological characteristics of bone marrow mesenchymal stem cells in acute myeloid leukemia with those from non-leukemia]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009;17:395–399.
   PubMedGoogle Scholar
• Currie GA. Platelet-derived growth-factor requirements for in vitro proliferation of normal and malignant mesenchymal cells. Br J Cancer. 1981;43:335–343.
   PubMed Web of Science ®Google Scholar
• Ng F, Boucher S, Koh S, et al. PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood. 2008;112:295–307.
   PubMed Web of Science ®Google Scholar
• Ball SG, Worthington JJ, Canfield AE, et al. Mesenchymal stromal cells: inhibiting PDGF receptors or depleting fibronectin induces mesodermal progenitors with endothelial potential. Stem Cells. 2014;32:694–705.
   PubMed Web of Science ®Google Scholar
• Ravasi T, Suzuki H, Cannistraci CV, et al. An atlas of combinatorial transcriptional regulation in mouse and man. Cell. 2010;140:744–752.
   PubMed Web of Science ®Google Scholar
• Müller-Tidow C, Schwäble J, Steffen B, et al. High-throughput analysis of genome-wide receptor tyrosine kinase expression in human cancers identifies potential novel drug targets. Clin Cancer Res. 2004;10:1241–1249.
   PubMed Web of Science ®Google Scholar
• Bigildeev AE, Zhironkina OA, Shipounova IN, et al. Clonal composition of human multipotent mesenchymal stromal cells. Exp Hematol. 2012;40:847–856.e4.
   PubMed Web of Science ®Google Scholar
• Fouillard L, Francois S, Bouchet S, et al. Innovative cell therapy in the treatment of serious adverse events related to both chemo-radiotherapy protocol and acute myeloid leukemia syndrome: the infusion of mesenchymal stem cells post-treatment reduces hematopoietic toxicity and promotes hematopoietic reconstitution. Curr Pharm Biotechnol. 2014;14:842–848.
   Web of Science ®Google Scholar
• Domenech J, Linassier C, Gihana E, et al. Prolonged impairment of hematopoiesis after high-dose therapy followed by autologous bone marrow transplantation. Blood. 1995;85:3320–3327.
   PubMed Web of Science ®Google Scholar
• Domenech J, Roingeard F, Binet C. The mechanisms involved in the impairment of hematopoiesis after autologous bone marrow transplantation. Leuk Lymphoma. 1997;24:239–256.
   PubMed Web of Science ®Google Scholar
• Lin Z, Kong Y, Wang Y, et al. [Analysis of risk factors for secondary cytopenia after allogeneic hematopoietic stem cell transplantation]. Zhonghua Xue Ye Xue Za Zhi. 2014;35:4–8.
   PubMedGoogle Scholar
• Gaundar SS, Bradstock KF, Bendall LJ. p38MAPK inhibitors attenuate cytokine production by bone marrow stromal cells and reduce stroma-mediated proliferation of acute lymphoblastic leukemia cells. Cell Cycle. 2014;8:2977–2985.
   Google Scholar
• Cogle CR, Goldman DC, Madlambayan GJ, et al. Functional integration of acute myeloid leukemia into the vascular niche. Leukemia. 2014;28:1978–1987.
   PubMed Web of Science ®Google Scholar
• de Bont ESJM, Neefjes VME, Rosati S, et al. New vessel formation and aberrant VEGF/VEGFR signaling in acute leukemia: does it matter? Leuk Lymphoma. 2002;43:1901–1909.
   PubMed Web of Science ®Google Scholar